HOME Top Market Reports Metabolomics (Biomarker Discovery/Metabolite Detection/Metabolite Profiling) Market By Applications (Drug Discovery/Toxicology Assessment/ Diagnosis) and Indications (Oncology/Cardiology/Neurology) – Forecasts from 2012 to 2017

Metabolomics (Biomarker Discovery/Metabolite Detection/Metabolite Profiling) Market By Applications (Drug Discovery/Toxicology Assessment/ Diagnosis) and Indications (Oncology/Cardiology/Neurology) – Forecasts from 2012 to 2017

By: marketsandmarkets.com
Publishing Date: January 2013
Report Code: MD 1360

 

Enquiry Before Buying
Analyst Briefing  
purchase report
download pdf  request for customisation


Over the last decade, genomics and proteomics have been used as key tools to discover potential drug targets and to better understand the complexities of biology. To balance research in these areas, metabolomics, a new science is evolving for analyzing the basic metabolic changes taking place in a living organism. Metabolomics is thus an emerging concept which refers to the systematic study of the distinctive chemical fingerprints generated in a particular cellular process.

Metabolomics Market – Analysis of Global Technology, Application Trends and Landscape 2012-2017 report covers the market by disease indications along with the applications and metabolite profiling for biomarker discovery applications. In addition, it also includes the factors driving and restraining the market and covers the market scenario in the U.S., Europe, Asia and the Rest of the World (ROW). This report will provide the company profiles of key companies along with the competitive analysis.

The Global Metabolomics market is showing a double digit growth (CAGR 35%) due to supportive factors such as, (i) increased willingness of biotechnology and pharma companies to adopt metabolomics concept to drive R&D activity within the industry, (ii) rapid growth of metabolomics data analysis softwares and solutions, and (iii) the advancement of analytical technologies. Metabolomics is used in the identification of new biomarkers, which indicate a change in the physiological state of a cell or tissue. Biomarker screening is important in the process of new drug discovery, and is also a key in vitro diagnostics tool. Additionally it is also being used for environmental toxicology screening. While, there are major concerns of this market such as the validation challenges, the positive aspects may very well offset the market restraints to aid the market grow at an exceptional rate.

The report also profiles leading participants of this industry with their recent developments and other strategic industry activities. These include: Metabolon Inc (U.S.), Metanomics (Germany), Metabolomic Technologies Inc. (U.S.), Human Metabolome Technologies (Japan), Beckman Coulter (U.S.), Agilent Technologies Inc (U.S.), Bruker Corporation (U.S.), Waters Corporation (U.S.), Biocrates Lifesciences (Austria), Chenomx Inc (Canada), Eisai co. ltd (Japan), Nextgen Metabolomics (U.S.), Phenomenome Discoveries Inc. (Canada) and Metabolomic Discoveries (Germany).

Scope of the Report

  • This technology report categorizes the market for metabolomics by geographical region (including the important countries in each region), applications, and indications, forecasting the market value in revenue by analyzing the trends in detection instruments and separation techniques (E.g. HPLC, Capillary Electrophoresis).
  • A detailed description of global technological developments and evolving trends in the field of metabolomics with key prominence on product innovations by industries and collaborative efforts by the academic research institutions.
  • A comprehensive picture of different types of detection instruments available for metabolite analysis (e.g. Mass Spectrometry, NMR, Electrochemical detection and Ion mobility spectrometer), prioritized based on critical criterias through Analytical Hierarchy Process (AHP).
  • An impact analysis of major drivers, restraints and challenges influencing the adoption and growth of metabolomics market during the forecast period from 2012 to 2017.
  • Market size - Global market forecast for the next 5 years from 2012 – 2017 by  including demand side analysis and strategic recommendations for technology/product developers.
  • Competitive landscape based on the analysis of key patents and research publications that gives an insight into prominent activities and global participants.

TABLE OF CONTENTS

1 INTRODUCTION       
   1.1 KEY TAKE-AWAYS       
   1.2 REPORT SCOPE       
   1.3 RESEARCH METHODOLOGY      
   1.4 KEY DATA POINTS FROM SECONDARY SOURCES     
         
2 EXECUTIVE SUMMARY      
         
3 METABOLOMICS –TECHNOLOGY LANDSCAPE ANALYSIS   
   3.1 INTRODUCTION       
   3.2 METABOLOMICS AND METABONOMICS     
   3.3 SEPARATION TECHNIQUES - HIGH PERFORMANCE LIQUID CHROMATOGRAPHY (HPLC) 
   3.4 SEPARATION TECHNIQUES – CAPILLARY ELECTROPHORESIS (CE)   
   3.5 DETECTION TECHNIQUES – MASS SPECTROMETRY (MS)    
   3.6 DETECTION TECHNIQUES – NUCLEAR MAGNETIC RESONANCE (NMR)   
   3.7 DETECTION TECHNIQUES – SURFACE BASED MASS ANALYSIS   
   3.8 KEY APPLICATION AREAS      
         3.8.1 BIOMARKER DISCOVERY     
         3.8.2 DRUG DISCOVERY      
         3.8.3 TOXICITY ASSESSMENT/TOXICOLOGY    
         3.8.4 NUTRI-GENOMICS       
   3.9 CONCEPTUAL APPROACH      
         3.9.1 TARGET ANALYSIS      
         3.9.2 METABOLITE PROFILING     
         3.9.3 METABOLITE FINGERPRINTING     
   3.10 TECHNOLOGY TRENDS IN METABOLOMICS      
   3.11 VALUE CHAIN ANALYSIS      
         
4 METABOLOMICS – MARKET LANDSCAPE ANALYSIS    
   4.1 GLOBAL METABOLOMICS MARKET SEGMENTATION    
   4.2 MARKET FORECAST       
         4.2.1 GLOBAL METABOLOMICS MARKET REVENUE FORECAST – INTRODUCTION  
         4.2.2 GLOBAL METABOLOMICS MARKET REVENUE – REGIONAL   
         4.2.3 GLOBAL METABOLOMICS MARKET REVENUE – INDICATION   
         4.2.4 GLOBAL METABOLOMICS MARKET REVENUE, BY APPLICATION  
   4.3 MARKET DYNAMICS       
         4.3.1 DRIVERS       
         4.3.2 RESTRAINTS      
         4.3.3 CHALLENGES      
         4.3.4 EMERGING TRENDS      
   4.4 DEMAND SIDE ANALYSIS      
         
5 METABOLOMICS - TECHNOLOGY INVESTMENT POTENTIAL 70-81   
   5.1 INVESTMENT CLIMATE ASSESSMENT     
         5.1.1 INVESTMENT CLIENT NETWORKS     
                  5.1.1.1 FUNDING BODIES     
                  5.1.1.2 INSIGHTS ON CURRENT & FUTURE TECH-INVESTMENT TREND 
         5.1.2 FUNDING OPPORTUNITIES     
         5.1.3 ANALYSIS OF POTENTIAL AREAS FOR TECHNOLOGY INVESTMENT USING STRATEGIC EVALUATION
         
6 METABOLOMICS – GEOGRAPHICAL ANALYSIS    
   6.1 INTRODUCTION       
   6.2 U.S., CANADA, MEXICO      
   6.3 EUROPE        
   6.4 ASIA & REST OF THE WORLD (ROW)     
         
7 COMPETITIVE LANDSCAPE ANALYSIS     
   7.1 MERGERS & ACQUISITIONS      
   7.2 NEW PRODUCT DEVELOPMENTS      
   7.3 COLLABORATIONS       
         
8 PATENT ANALYSIS       
   8.1 PATENT ANALYSIS       
         
9 TECHNOLOGY ANALYSIS  (USING MULTI CRITERIA DECISION MAKING) & ROAD MAPPING 94-100      
   9.1 LEVEL 0 CRITERIA DESCRIPTION      
   9.2 COMPARISON OF DEVICES BASED ON LEVEL 0 CRITERIA    
   9.3 TECHNOLOGY PRIORITIZATION AND AHP ANALYSIS FINDINGS   
   9.4 TECHNOLOGY ROADMAP      
         
10 ANALYST INSIGHTS & RECOMMENDATIONS    
     10.1 ANALYST INSIGHTS       
     10.2 STRATEGIC RECOMMENDATIONS FOR TECHNOLOGY & BUSINESS MANAGEMENT  
         
11 COMPANY PROFILES      
     11.1 AGILENT TECHNOLOGIES      
     11.2 BRUKER CORPORATION      
     11.3 METABOLOMIC TECHNOLOGIES     
     11.4 METABOLON        
     11.5 CHENOMX        
     11.6 BIO-RAD LABORATORIES      
     11.7 WATERS CORPORATION      
     11.8 HUMAN METABOLOME TECHNOLOGIES     
     11.9 NEXTGEN METABOLOMICS      
     11.10 BIOCRATES LIFE SCIENCES AG      
     11.11 STEMINA BIOMARKER      
     11.12 PHENOMENOME       
     11.13 METANOMICS GMBH      
     11.14 ACCELRYS       
     11.15 EISAI CO. LTD.       
     11.16 SHIMADZU CORPORATION      
     11.17 SIDMAP, LLC       
     11.18 ASTRAZENECA PLC       
     11.19 AB SCIEX        
     11.2 METABOLOMX       
     11.21 RESEARCH INSTITUTE OF CHROMATOGRAPHY (RIC)       
         
12 APPENDIX       
     12.1 KEY PATENTS       
         
13 GLOSSARY       

LIST OF TABLES        
         
TABLE 1 GLOBAL METABOLOMICS MARKET REVENUE, BY REGIONAL ($MILLION)   
TABLE 2 GLOBAL METABOLOMICS MARKET REVENUE, BY INDICATION ($MILLION)  
TABLE 3 GLOBAL METABOLOMICS MARKET REVENUE ($MILLION), Y-O-Y GROWTH (%), BY ONCOLOGY INDICATION
TABLE 4 GLOBAL METABOLOMICS MARKET REVENUE ($MILLION), Y-O-Y GROWTH (%), BY CARDIOLOGY INDICATION
TABLE 5 GLOBAL METABOLOMICS MARKET REVENUE ($MILLION), Y-O-Y GROWTH (%), BY NEUROLOGY INDICATION
TABLE 6 GLOBAL METABOLOMICS MARKET REVENUE ($MILLION), Y-O-Y GROWTH (%), BY OTHER INDICATIONS
TABLE 7 GLOBAL METABOLOMICS MARKET REVENUE, BY APPLICATION ($MILLION)  
TABLE 8 GLOBAL METABOLOMICS MARKET REVENUE ($MILLION), Y-O-Y GROWTH (%), BY BIO MARKER DISCOVERY APPLICATION
TABLE 9 GLOBAL METABOLOMICS MARKET REVENUE ($MILLION), Y-O-Y GROWTH (%), BY DRUG DISCOVERY APPLICATION
TABLE 10 GLOBAL METABOLOMICS MARKET REVENUE ($MILLION), Y-O-Y GROWTH (%), BY TOXICOLOGY TESTING APPLICATION
TABLE 11 GLOBAL METABOLOMICS MARKET REVENUE ($MILLION), Y-O-Y GROWTH (%), BY OTHER APPLICATIONS
         
LIST OF OTHER TABLES        
         
TABLE 1 MARKET DYNAMICS-DRIVERS IMPACT BY TIMELINE     
TABLE 2 MARKET DYNAMICS-RESTRAINTS IMPACT BY TIMELINE     
TABLE 3 OPPORTUNITY STRATEGIC EVALUATION ANALYSIS     
TABLE 4 MERGERS AND ACQUISITIONS      
TABLE 5 NEW PRODUCT DEVELOPMENTS       
TABLE 6 COLLABORATIONS        
TABLE 7 KEY PATENTS        

LIST OF FIGURES        
         
FIG 1 RESEARCH METHODOLOGY      
FIG 2  GLOBAL METABOLOMICS MARKET REVENUE, 2012 – 2017 ($MILLION)   
FIG 3 MARKET SHARE BY REGION, 2012 – 2017 (%)     
FIG 4 KEY APPLICATION AREAS       
FIG 5 FLOW CHART OF NUTRI-GENOMICS      
FIG 6 CONCEPTUAL APPROACH      
FIG 7 VALUE CHAIN ANALYSIS      
FIG 8 PERCENTAGE OF STAKE HOLDERS IN METABOLOMICS VALUE CHAIN   
FIG 9 GLOBAL METABOLOMICS MARKET SEGMENTATION    
FIG 10 GLOBAL METABOLOMICS MARKET REVENUE FORECAST, 2012 - 2017 ($MILLION)  
FIG 11 GLOBAL METABOLOMICS MARKET REVENUE, BY REGIONAL ($MILLION)   
FIG 12 GLOBAL METABOLOMICS MARKET Y-O-Y GROWTH RATE, BY REGION   
FIG 13 MARKET SHARE, BY REGION, 2012 – 2017 (%)     
FIG 14 GLOBAL METABOLOMICS MARKET REVENUE, BY INDICATION ($MILLION)  
FIG 15 GLOBAL METABOLOMICS MARKET REVENUE ($MILLION), Y-O-Y GROWTH (%), BY ONCOLOGY INDICATION
FIG 16 GLOBAL METABOLOMICS MARKET REVENUE ($MILLION), Y-O-Y GROWTH (%), BY CARDIOLOGY INDICATION
FIG 17 GLOBAL METABOLOMICS MARKET REVENUE ($MILLION), Y-O-Y GROWTH (%), BY NEUROLOGY INDICATION
FIG 18 GLOBAL METABOLOMICS MARKET REVENUE ($MILLION), Y-O-Y GROWTH (%), BY OTHER INDICATIONS
FIG 19 GLOBAL MARKET SHARE, BY INDICATION, 2012 – 2017 (%)    
FIG 20 GLOBAL METABOLOMICS MARKET REVENUE, BY APPLICATION ($MILLION)  
FIG 21 GLOBAL METABOLOMICS MARKET REVENUE ($MILLION), Y-O-Y GROWTH (%), BY BIO MARKER DISCOVERY APPLICATION
FIG 22 GLOBAL METABOLOMICS MARKET REVENUE ($MILLION), Y-O-Y GROWTH (%), BY DRUG DISCOVERY APPLICATION
FIG 23 GLOBAL METABOLOMICS MARKET REVENUE ($MILLION), Y-O-Y GROWTH (%), BY TOXICOLOGY TESTING APPLICATION
FIG 24 GLOBAL METABOLOMICS MARKET REVENUE ($MILLION), Y-O-Y GROWTH (%), BY OTHER APPLICATIONS
FIG 25 GLOBAL PERCENTAGE DISTRIBUTION OF METABOLOMICS MARKET, BY APPLICATIONS, 2012 – 2017 (%)
FIG 26 DEMAND SIDE ANALYSIS       
FIG 27 INVESTMENT CLIENT NETWORKS      
FIG 28 OPPORTUNITY STRATEGIC EVALUATION ANALYSIS    
FIG 29 REGIONS WITH HIGH TECHNOLOGY ADOPTION     
FIG 30 PATENT DISTRIBUTION AMONG TOP PLAYERS     
FIG 31 AHP ANALYSIS       
FIG 32 PRIORITY VALUES       
FIG 33 COMPARISON OF DEVICES BASED ON LEVEL 0 CRITERIA    
FIG 34 TECHNOLOGY PRIORITIZATION AND AHP ANALYSIS FINDINGS   
FIG 35 TECHNOLOGY ROADMAP      
FIG 36 STRATEGIC RECOMMENDATIONS FOR TECHNOLOGY & BUSINESS MANAGEMENT  

 

Metabolomics is an emerging and dynamic concept which refers to the systematic study of the distinctive chemical fingerprints generated in a particular cellular process. Metabolic profiling offers an immediate snapshot of a cell's physiology which is not possible with the existing “omics” techniques such as proteomics and genomics. In future, metabolomics will become a standard tool in the pharma and biotech sectors driven by the identification of new biomarkers co-related with many clinical conditions.

Metabolomics is one of the fastest growing markets in the scientific arena, finding its application in essential fields such as drug discovery, toxicology assessment, nutrigenomics and biomarker discovery. The key reason for rapid growth of the metabolomics market is its cost effectiveness in the diagnostics sector, particularly when compared to other “omics” based methods of biomarker detection.

The application of metabolomics spans many markets and can be used to address important trends and challenges in Life Sciences. The global market for metabolomics in terms of revenue is estimated to be worth $343 million in 2012 and is expected to reach $1.5 billion by 2017, growing at a CAGR of 35% from 2012 to 2017.

GLOBAL METABOLOMICS MARKET BY GEOGRAPHY

Metabolomics Technology Market 

Source: MarketsandMarkets Analysis

Currently, metabolomics market is developing rapidly in U.S. and Europe. Apart from these two regions, countries such as Japan, China and Australia are extensively focusing on metabolomics market to gain market share and improve profitability on owing to its promising growth.

  • Metabolomics Market

    Metabolomics is being successfully used for lead compound discovery and optimization; for biomarker identification to measure disease progression; to understand drug mechanism of action, efficacy and monitor drug metabolism; and to determine the safety and toxicity of drugs.

    Since the crucial role of metabolomics is successfully validated for use in a) lead compound discovery and optimization, b) biomarker identification to measure disease progression, c) to understand a drug’s mechanism of action, efficacy and monitor drug metabolism, the pharmaceutical companies have begun embracing this new “omics” platform in drug discovery. The market participants have thus shifted their focus on technological advancements to develop next generation techniques for metabolite detection. Further, the research discoveries on the use of metabolomics in other application areas such as agriculture, biofuels, food and diet evaluation is driving investment opportunities in this area.

    Key participants in the global metabolomics market are METABOLON (U.S.), METANOMICS (GERMANY), HUMAN METABOLOME TECNOLOGY (JAPAN), AGILENT (U.S), BRUKER CORPORATION (U.S.). Other players involved include Beckman Coulter (U.S.), Waters Corporation (U.S.), Biocrates Lifesciences (Austria), Chenomx Inc (Canada), Eisai co. ltd (Japan), Nextgen Metabolomics (U.S.), Phenomenome Discoveries Inc. (Canada) and Metabolomic Discoveries (Germany)

  • Custom Market Research Services

    We will customize the research for you, in case the report listed above does not meet with your exact requirements. Our custom research will comprehensively cover the business information you require to help you arrive at strategic and profitable business decisions.

    Please visit http://www.marketsandmarkets.com/knowledge-process-outsourcing-services.asp to specify your custom Research Requirement

    Connect With Us

    Follow us on LinkedIn  Follow us on Facebook   Follow us on Twitter 
    Live Chat Support


    US : 1-888-600-6441
    UK : 44-800-368-9399

    Search reports